How do you pay?

How to pay the least

Ask for the cash price

Gomekli

We didn’t find one.

  1. Ask your pharmacy for Gomekli’s cash price, and one or two other pharmacies too.
  2. Gomekli’s savings card works only with insurance from a job or one you bought.

Compare every option

Question
Brand nameGomekli
Authorized genericmirdametinib
Regular genericmirdametinib
What you’d pay
Cash priceAsk the pharmacy
Not soldThere isn’t one
Not soldNone found
Same as Gomekli?
The original
–
–

Brand nameThe maker’s card

SpringWorks CareConnections Commercial Copay Program

Savings card from SpringWorks Therapeutics

No insuranceNeeds insuranceNo cash price listed.
Insurance · as little as $0 for a 21-day supply

Sign up on gomekli.com 

Or call 1-844-227-3755.

In the maker’s words

“Commercially insured patients may pay as little as a $0 copay per 21-day supply of GOMEKLI with the Commercial Copay Program.”

From the maker’s offer on gomekli.com, checked November 2, 2026. Co-pay cards can’t be used with Medicare (including Medicare Advantage), Medicaid, TRICARE or VA.

Maker’s card or discount card?

A discount card like GoodRx lowers the pharmacy’s cash price, but for a brand-name drug that price often stays high. Compare it with the maker’s card above. You can usually use one or the other on a fill, not both.

Authorized genericNot sold

There isn’t one. An authorized generic is Gomekli itself, from the same company, sold without the brand name, and usually for less. For now Gomekli is the only choice; its maker’s savings card can lower what you pay.

See the brand name →

Regular genericNot sold

We didn’t find one. Generics usually come once the brand’s patents and exclusivity end. Until then, the maker’s savings card is the way to pay less.

See the brand name →

What it’s used for

What the FDA label says

GOMEKLI is a kinase inhibitor indicated for the treatment of adult and pediatric patients 2 years of age and older with neurofibromatosis type 1 (NF1) who have symptomatic plexiform neurofibromas (PN) not amenable to complete resection.

Source: the FDA label for Gomekli (SpringWorks Therapeutics, Inc.), July 10, 2026. Full label on DailyMed 

Good to know